These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis. Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066 [TBL] [Abstract][Full Text] [Related]
3. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124 [TBL] [Abstract][Full Text] [Related]
4. Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas. Benhamida JK; Vyas M; Tanaka A; Wang L; Bahrami A; Ozcan K; Basturk O; Villafania L; Mata DA; El Jabbour T; Selenica P; Roehrl MHA; Weigelt B; Reis-Filho JS; Scaltriti M; Klimstra DS Mod Pathol; 2022 Jul; 35(7):956-961. PubMed ID: 34969956 [TBL] [Abstract][Full Text] [Related]
5. Surgical and molecular pathology of pancreatic neoplasms. Hackeng WM; Hruban RH; Offerhaus GJ; Brosens LA Diagn Pathol; 2016 Jun; 11(1):47. PubMed ID: 27267993 [TBL] [Abstract][Full Text] [Related]
6. Nonductal Pancreatic Cancers. Jun SY; Hong SM Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361 [TBL] [Abstract][Full Text] [Related]
7. Methylation profile of circulating plasma DNA in patients with pancreatic cancer. Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA. Wu H; Guo S; Liu X; Li Y; Su Z; He Q; Liu X; Zhang Z; Yu L; Shi X; Gao S; Wang H; Pan Y; Ma C; Liu R; Dai M; Jin G; Liang Z BMC Med; 2022 Nov; 20(1):458. PubMed ID: 36434648 [TBL] [Abstract][Full Text] [Related]
9. A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification. Fang JM; Shi J Arch Pathol Lab Med; 2019 Nov; 143(11):1317-1326. PubMed ID: 31509453 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling. Endo Y; Fujimoto M; Ito N; Takahashi Y; Kitago M; Gotoh M; Hiraoka N; Yoshida T; Kitagawa Y; Kanai Y; Arai E J Cancer Res Clin Oncol; 2021 May; 147(5):1341-1354. PubMed ID: 33635431 [TBL] [Abstract][Full Text] [Related]
14. Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma. Antonello D; Gobbo S; Corbo V; Sipos B; Lemoine NR; Scarpa A Pancreatology; 2009; 9(1-2):25-33. PubMed ID: 19077452 [TBL] [Abstract][Full Text] [Related]
15. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction? Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466 [TBL] [Abstract][Full Text] [Related]
16. Nonductal neoplasms of the pancreas. Klimstra DS Mod Pathol; 2007 Feb; 20 Suppl 1():S94-112. PubMed ID: 17486055 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive study of semi-supervised learning for DNA methylation-based supervised classification of central nervous system tumors. Tran QT; Alom MZ; Orr BA BMC Bioinformatics; 2022 Jun; 23(1):223. PubMed ID: 35676649 [TBL] [Abstract][Full Text] [Related]
18. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670 [TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma. Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]